North America Structured
Investments 4yr INDU/SPX Uncapped Accelerated Barrier Notes J.P. Morgan Structured Investments | 1 800 576 3529 | jpm_structured_investments@jpmorgan.com
The following is a summary of the terms of the notes offered by the preliminary pricing supplement highlighted below. Summary of Terms
Issuer: JPMorgan Chase Financial Company LLC Guarantor: JPMorgan Chase & Co. Minimum Denomination: $1,000 Underlyings: Dow Jones Industrial
Average® and S&P 500® Index Upside Leverage Factor: At least 1.41* Barrier Amount: With respect to each Underlying, 75.00% of its Initial
Value Underlying Return: (Final Value – Initial Value) / Initial Value Pricing Date: July 17, 2026 Observation Date: July 17, 2030 Maturity
Date: July 22, 2030 CUSIP: 46661CGB6 Preliminary Pricing Supplement: http://sp.jpmorgan.com/document/cusip/46661CGB6/doctype/Product_Termsheet/document.pdf
Estimated Value: The estimated value of the notes, when the terms of the notes are set, will not be less than $900.00 per $1,000 principal
amount note. For information about the estimated value of the notes, which likely will be lower than the price you paid for the notes,
see the hyperlink above. Payment at Maturity If the Final Value of each Underlying is greater than its Initial Value, your payment at
maturity per $1,000 principal amount note will be calculated as follows: $1,000 + ($1,000 × Lesser Performing Underlying Return × Upside
Leverage Factor) If the Final Value of either Underlying is equal to or less than its Initial Value but the Final Value of each Underlying
is greater than or equal to its Barrier Amount, you will receive the principal amount of your notes at maturity. If the Final Value of
either Underlying is less than its Barrier Amount, your payment at maturity per $1,000 principal amount note will be calculated as follows:
$1,000 + ($1,000 × Lesser Performing Underlying Return) If the Final Value of either Underlying is less than its Barrier Amount, you
will lose more than 25.00% of your principal amount at maturity and could lose all of your principal amount at maturity. Any payment
on the notes is subject to the credit risk of JPMorgan Chase Financial Company LLC, as issuer of the notes and the credit risk of JPMorgan
Chase & Co., as guarantor of the notes. * The actual Upside Leverage Factor will be provided in the pricing supplement and will not be
less than 1.41. ** Reflects an Upside Leverage Factor of 1.41 for illustrative purposes. The hypothetical returns and hypothetical payments
on the notes shown above apply only at maturity. These hypotheticals do not reflect fees or expenses that would be associated with any
sale in the secondary market. If these fees and expenses were included, the hypothetical returns and hypothetical payments shown above
would likely be lower. Hypothetical Returns on the Notes at Maturity** Underlying Performance Note Payoff at Maturity Payment at Maturity
Underlying Return Hypothetical Lesser Performing Underlying Return Hypothetical Note Return Hypothetical Payment at Maturity 100.00%
141.00% $2,410.00 80.00% 112.80% $2,128.00 60.00% 84.60% $1,846.00 40.00% 56.40% $1,564.00 30.00% 42.30% $1,423.00 20.00% 28.20% $1,282.00
10.00% 14.10% $1,141.00 5.00% 7.05% $1,070.50 0.00% 0.00% $1,000.00 -10.00% 0.00% $1,000.00 -20.00% 0.00% $1,000.00 -25.00% 0.00% $1,000.00
-25.01% -25.01% $749.90 -30.00% -30.00% $700.00 -50.00% -50.00% $500.00 -60.00% -60.00% $400.00 -80.00% -80.00% $200.00 -100.00% -100.00%
$0.00
North America Structured Investments 4yr
INDU/SPX Uncapped Accelerated Barrier Notes J.P. Morgan Structured Investments | 1 800 576 3529 | jpm_structured_investments@jpmorgan.com
Selected Risks œ Your investment in the notes may result in a loss. The notes do not guarantee any return of principal. œ Your payment
at maturity will be determined by the Lesser Performing Underlying. œ The benefit provided by the Barrier Amount may terminate on the
Observation Date. œ You are exposed to the risk of decline in the value of each Underlying. œ Any payment on the notes at maturity
is subject to the credit risks of JPMorgan Chase Financial Company LLC and JPMorgan Chase & Co. Therefore the value of the notes prior
to maturity will be subject to changes in the marketfs view of the creditworthiness of JPMorgan Chase Financial Company LLC or JPMorgan
Chase & Co. œ No interest payments, dividend payments or voting rights. œ JPMorgan Chase & Co. is currently one of the companies that
make up the S&P 500R Index and the Dow Jones Industrial Average.. œ As a finance subsidiary, JPMorgan Chase Financial Company LLC has
no independent activities and has limited assets. Selected Risks (continued) œ The estimated value of the notes will be lower than the
original issue price (price to public) of the notes. œ The estimated value of the notes is determined by reference to an internal funding
rate. œ The estimated value of the notes does not represent future values and may differ from othersf estimates. œ The value of the
notes, which may be reflected in customer account statements, may be higher than the then current estimated value of the notes for a
limited time period. œ Lack of liquidity: J.P. Morgan Securities LLC (who we refer to as JPMS), intends to offer to purchase the notes
in the secondary market but is not required to do so. The price, if any, at which JPMS will be willing to purchase notes from you in
the secondary market, if at all, may result in a significant loss of your principal. œ Potential conflicts: We and our affiliates play
a variety of roles in connection with the issuance of the notes, including acting as calculation agent and hedging our obligations under
the notes, and making the assumptions used to determine the pricing of the notes and the estimated value of the notes when the terms
of the notes are set. It is possible that such hedging or other trading activities of J.P. Morgan or its affiliates could result in substantial
returns for J.P. Morgan and its affiliates while the value of the notes declines. œ The tax consequences of the notes may be uncertain.
You should consult your tax adviser regarding the U.S. federal income tax consequences of an investment in the notes. The risks identified
above are not exhaustive. Please see gRisk Factorsh in the prospectus supplement and the applicable product supplement and gSelected
Risk Considerationsh in the applicable preliminary pricing supplement for additional information. Additional Information SEC Legend:
JPMorgan Chase Financial Company LLC and JPMorgan Chase & Co. have filed a registration statement (including a prospectus) with the SEC
for any offerings to which these materials relate. Before you invest, you should read the prospectus in that registration statement and
the other documents relating to this offering that JPMorgan Chase Financial Company LLC and JPMorgan Chase & Co. has filed with the SEC
for more complete information about JPMorgan Chase Financial Company LLC and JPMorgan Chase & Co. and this offering. You may get these
documents without cost by visiting EDGAR on the SEC web site at www.sec.gov. Alternatively, JPMorgan Chase Financial Company LLC and
JPMorgan Chase & Co., any agent or any dealer participating in this offering will arrange to send you the prospectus and each prospectus
supplement as well as any product supplement, underlying supplement and preliminary pricing supplement if you so request by calling toll-free
1-866-535-9248. IRS Circular 230 Disclosure: JPMorgan Chase & Co. and its affiliates do not provide tax advice. Accordingly, any discussion
of U.S. tax matters contained herein (including any attachments) is not intended or written to be used, and cannot be used, in connection
with the promotion, marketing or recommendation by anyone unaffiliated with JPMorgan Chase & Co. of any of the matters addressed herein
or for the purpose of avoiding U.S. tax-related penalties. Investment suitability must be determined individually for each investor,
and the financial instruments described herein may not be suitable for all investors. This information is not intended to provide and
should not be relied upon as providing accounting, legal, regulatory or tax advice. Investors should consult with their own advisers
as to these matters. This material is not a product of J.P. Morgan Research Departments. Free Writing Prospectus Filed Pursuant to Rule
433, Registration Statement Nos. 333-293684 and 333-293684-01